PLATELET-ACTIVATING-FACTOR - A MEDIATOR FOR CLINICIAN

被引：134
作者：
IMAIZUMI, TA
STAFFORINI, DM
YAMADA, Y
MCINTYRE, TM
PRESCOTT, SM
ZIMMERMAN, GA
机构：
[1] UNIV UTAH, MED CTR, CVRTI, NORA ECCLES HARRISON CARDIOVASC RES & TRAINING IN, SALT LAKE CITY, UT 84112 USA
[2] UNIV UTAH, DEPT INTERNAL MED, SALT LAKE CITY, UT 84112 USA
[3] UNIV UTAH, DEPT BIOCHEM, SALT LAKE CITY, UT 84112 USA
来源：
JOURNAL OF INTERNAL MEDICINE | 1995年 / 238卷 / 01期
关键词：
D O I：
10.1111/j.1365-2796.1995.tb00894.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：5 / 20
页数：16
相关论文
共 112 条
[1]   OXYGEN RADICALS INHIBIT HUMAN PLASMA ACETYLHYDROLASE, THE ENZYME THAT CATABOLIZES PLATELET-ACTIVATING-FACTOR [J].
AMBROSIO, G ;
ORIENTE, A ;
NAPOLI, C ;
PALUMBO, G ;
CHIARIELLO, P ;
MARONE, G ;
CONDORELLI, M ;
CHIARIELLO, M ;
TRIGGIANI, M .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2408-2416
[2]   CEREBROSPINAL-FLUID CACHECTIN TUMOR NECROSIS FACTOR-ALPHA AND PLATELET-ACTIVATING FACTOR CONCENTRATIONS AND SEVERITY OF BACTERIAL-MENINGITIS IN CHILDREN [J].
ARDITI, M ;
MANOGUE, KR ;
CAPLAN, M ;
YOGEV, R .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) :139-147
[3]   URINARY-EXCRETION OF PLATELET-ACTIVATING-FACTOR IN HEMOLYTIC UREMIC SYNDROME [J].
BENIGNI, A ;
BOCCARDO, P ;
NORIS, M ;
REMUZZI, G ;
SIEGLER, RL .
LANCET, 1992, 339 (8797) :835-836
[4]   IDENTIFICATION OF PHOSPHOLIPID PLATELET-ACTIVATING FACTOR (1-0-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE) IN HUMAN AMNIOTIC-FLUID AND URINE [J].
BILLAH, MM ;
JOHNSTON, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 113 (01) :51-58
[5]   ANTIHYPERTENSIVE ACTIVITY OF AN ALKYL ETHER ANALOG OF PHOSPHATIDYLCHOLINE [J].
BLANK, ML ;
SNYDER, F ;
BYERS, LW ;
BROOKS, B ;
MUIRHEAD, EE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 90 (04) :1194-1200
[6]   IS THERE A CASE FOR PAF ANTAGONISTS IN THE TREATMENT OF ISCHEMIC STATES [J].
BRAQUET, P ;
PAUBERTBRAQUET, M ;
KOLTAI, M ;
BOURGAIN, R ;
BUSSOLINO, F ;
HOSFORD, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (01) :23-30
[7]   ROLE OF CYTOKINES AND PLATELET-ACTIVATING FACTOR IN MICROVASCULAR IMMUNE INJURY [J].
BRAQUET, P ;
HOSFORD, D ;
BRAQUET, M ;
BOURGAIN, R ;
BUSSOLINO, F .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1989, 88 (1-2) :88-100
[8]  
BRAQUET P, 1987, PHARMACOL REV, V39, P97
[9]   INTRAVASCULAR RELEASE OF PLATELET ACTIVATING FACTOR IN CHILDREN WITH SEPSIS [J].
BUSSOLINO, F ;
PORCELLINI, MG ;
VARESE, L ;
BOSIA, A .
THROMBOSIS RESEARCH, 1987, 48 (05) :619-620
[10]   NECROTIZING ENTEROCOLITIS - ROLE OF PLATELET ACTIVATING FACTOR, ENDOTOXIN, AND TUMOR-NECROSIS-FACTOR [J].
CAPLAN, MS ;
HSUEH, W .
JOURNAL OF PEDIATRICS, 1990, 117 (01) :S47-S51
12345678910